Xin Huang

5PUBLICATIONS
38CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 09, 2026
Spatiotemporal Immune Determinants of Response to Immune Rechallenge in Advanced Cervical Cancer.

Chunyan Lan, Peidong Zhang, Jing Zhao

|Oct 30, 2025
The INSPECTOR study: enhanced feasibility for clinical translation of a multi-cancer early detection method based on enzyme-assisted high signal-to-noise ratio sequencing of methylated circulating tumor DNA.

Hui-Yan Luo, Wei Wei, Pansong Li

|May 14, 2024
Long-term survival outcomes and immune checkpoint inhibitor retreatment in patients with advanced cervical cancer treated with camrelizumab plus apatinib in the phase II CLAP study.

Chunyan Lan, Huaiwu Lu, Lin Zhou

|Feb 19, 2024
Cadonilimab Combined with Chemotherapy with or without Bevacizumab as First-Line Treatment in Recurrent or Metastatic Cervical Cancer (COMPASSION-13): A Phase 2 Study.

Hanmei Lou, Hongbing Cai, Xin Huang

|Oct 14, 2020
Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial.

Chunyan Lan, Jingxian Shen, Yin Wang

Pageof 1

Frequent Collaborators

2 joint publications

Haixi Liang

1 joint publications

Yanhong Deng

1 joint publications

Hanmei Lou

1 joint publications

Hongbing Cai